Dihydrocucurbitacin B

Cat. No.: X22-05-ZQ645

Dihydrocucurbitacin B

Synonym: 13201-14-4; Dihydrocucurbitacin B; 23,24-Dihydrocucurbitacin B; [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-Dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-Hydroxy-2-methyl-5-oxoheptan-2-yl] acetate

  • CAS Number: 13201-14-4
  • Compound CID: 267250
Product Size
10 mg; 20 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Dihydrocucurbitacin B inhibits nuclear factor of activated T cells (NFAT), induces cell cycle arrested in the G0 phase, and inhibits delayed type hypersensitivity. This product can be used for research in the fields of medicine and pharmacy.
Molecular Weight
560.72
Molecular Formula
C32H48O8
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Applications
Dihydrocucurbitacin B can be used for research in the fields of medicine and pharmacy.
Storage
Store at 4°C.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.